Skip to main content

Table 2 The mean Foxp3/CD3 and Foxp3/CD4 ratios according to the patient group

From: Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer

  Cancer Node positive Node negative Control
Foxp3:CD3* 0.24 0.26 0.17 0.14
Foxp3:CD4* 0.29 0.31 0.19 0.14
  1. Ratio of Foxp3+ cells to that of other T cell markers.
  2. * p < 0.001 for cancer patients compared to controls, and node-positive patients compared to node-negative patients.